MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Learn how genetic testing aids in diagnosing Pallister-Hall Syndrome, a rare genetic disorder, by identifying GLI3 mutations for early intervention and personalized care.
Diagnose Paragangliomas 4 with genetic testing to identify SDHC mutations, guide treatment, monitor progression, and understand hereditary risks for better management.
CARD9 deficiency increases susceptibility to invasive fungal diseases. Genetic testing provides definitive diagnosis, personalized plans, and crucial family screening.
Explore the genetic basis and diagnosis of primary failure of tooth eruption (PFE). Learn how genetic testing aids in identifying mutations and creating personalized treatment…
Progressive Familial Heart Block, Type 1A: Explore symptoms, diagnosis methods like ECG and Holter monitoring, and the critical role of genetic testing in managing PFHB1A.
Learn about Renal Coloboma Syndrome, its diagnosis through clinical evaluations, imaging, and the crucial role of genetic testing in managing this genetic disorder.
Genetic testing plays a crucial role in diagnosing Schnyder Crystalline Corneal Dystrophy (SCCD). Learn about SCCD symptoms, diagnosis, and how genetic testing can help.
Explore how genetic testing identifies KCNQ2 and KCNQ3 mutations to diagnose benign familial neonatal seizures, ensuring accurate diagnosis and personalized treatment.